News
“Emcure claims that the vaccine and platform were developed by its minor subsidiary Gennova Biopharmaceuticals Ltd. Were that true, it would be stunning. Emcure and Gennova have no track record of ...
(Progress Report on Disclosed Matters) Notice Regarding Completion of JICC-04’s Tender Offer for Shares of a Consolidated Subsidiary of Fujitsu Limited (SHINKO ELECTRIC INDUSTRIES CO., LTD.) (PDF: ...
CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announced that Marc Rossiter has stepped down as President, CEO, and ...
ASX company news and announcements for Paradigm Biopharmaceuticals Limited (PAR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ...
WOODLAND HILLS, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a global, clinical-stage biotechnology company focused on the discovery and development of innovative ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
4The land has laid dormant for years, now £15m could help see it transformed 5GMP detain carjacker minutes after committing burglary in Rochdale To contact the Rochdale Online news desk, email ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results